Page last updated: 2024-08-17

folic acid and Cholangiitis, Sclerosing

folic acid has been researched along with Cholangiitis, Sclerosing in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ardizzone, S; Danese, S; Gasche, C; Hernández, V; Kariv, R; Marti-Gallostra, M; Myrelid, P; Sebastian, S; Spinelli, A; Toruner, M; Tsianos, E; van der Meulen-de Jong, AE; Yuksel, ES	1
Keach, J; Kremers, WK; Lindor, KD; Loftus, EV; Pardi, DS	1
Kroesen, A; Pox, C; Schmiegel, W	1

Reviews

1 review(s) available for folic acid and Cholangiitis, Sclerosing

Article	Year
Colorectal cancer in inflammatory bowel disease: results of the 3rd ECCO pathogenesis scientific workshop (I). Journal of Crohn's & colitis, 2014, Volume: 8, Issue:1 Topics: Age of Onset; Anticarcinogenic Agents; Cholangitis, Sclerosing; Colitis, Ulcerative; Colorectal Neoplasms; Congresses as Topic; Crohn Disease; Folic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunologic Factors; Mesalamine; Risk Factors; Survival Rate; Time Factors; Ursodeoxycholic Acid	2014

Article

Year

Colorectal cancer in inflammatory bowel disease: results of the 3rd ECCO pathogenesis scientific workshop (I).

Journal of Crohn's & colitis, 2014, Volume: 8, Issue:1

Topics: Age of Onset; Anticarcinogenic Agents; Cholangitis, Sclerosing; Colitis, Ulcerative; Colorectal Neoplasms; Congresses as Topic; Crohn Disease; Folic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunologic Factors; Mesalamine; Risk Factors; Survival Rate; Time Factors; Ursodeoxycholic Acid

2014

Trials

1 trial(s) available for folic acid and Cholangiitis, Sclerosing

Article	Year
Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology, 2003, Volume: 124, Issue:4 Topics: Adult; Aged; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Cholagogues and Choleretics; Cholangitis, Sclerosing; Colitis, Ulcerative; Colonic Neoplasms; Disease-Free Survival; Female; Folic Acid; Humans; Incidence; Male; Middle Aged; Risk Factors; Ursodeoxycholic Acid	2003

Article

Year

Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis.

Gastroenterology, 2003, Volume: 124, Issue:4

Topics: Adult; Aged; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Cholagogues and Choleretics; Cholangitis, Sclerosing; Colitis, Ulcerative; Colonic Neoplasms; Disease-Free Survival; Female; Folic Acid; Humans; Incidence; Male; Middle Aged; Risk Factors; Ursodeoxycholic Acid

2003

Other Studies

1 other study(ies) available for folic acid and Cholangiitis, Sclerosing

Article	Year
[Ulcerative colitis. Cancer prevention]. Zeitschrift fur Gastroenterologie, 2004, Volume: 42, Issue:9 Topics: Adenoma; Adenomatous Polyposis Coli; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biopsy; Case-Control Studies; Child; Cholagogues and Choleretics; Cholangitis, Sclerosing; Colectomy; Colitis, Ulcerative; Colon; Colorectal Neoplasms; Cross-Sectional Studies; Female; Folic Acid; Follow-Up Studies; Humans; Male; Meta-Analysis as Topic; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Ursodeoxycholic Acid	2004

Article

Year

[Ulcerative colitis. Cancer prevention].

Zeitschrift fur Gastroenterologie, 2004, Volume: 42, Issue:9

Topics: Adenoma; Adenomatous Polyposis Coli; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biopsy; Case-Control Studies; Child; Cholagogues and Choleretics; Cholangitis, Sclerosing; Colectomy; Colitis, Ulcerative; Colon; Colorectal Neoplasms; Cross-Sectional Studies; Female; Folic Acid; Follow-Up Studies; Humans; Male; Meta-Analysis as Topic; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Ursodeoxycholic Acid

2004